Cancer procoagulant in patients with adenocarcinomas

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 8, 2005, Pages 543-547

  Kaźmierczak, Maciej ^a,c   Lewandowski, Krzysztof ^a   Wojtukiewicz, Marek Z ^b   Turowiecka, Zofia ^a   Kołacz, Edyta ^a   Łojko, Anna ^a   Skrzydlewska, Elzbieta ^b   Zawilska, Krystyna ^a   Komarnicki, Mieczysław ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c NONE   (Poland)

Author keywords

Adenocarcinoma; Cancer procoagulant; Thrombosis

Indexed keywords

CANCER PROCOAGULANT; FIBRINOGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; THROMBIN ANTITHROMBIN COMPLEX;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL OBSERVATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEMOCONCENTRATION; HOSPITAL ADMISSION; HUMAN; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; STOMACH ADENOCARCINOMA; THROMBOEMBOLISM;

EID: 27844453849     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000188413.32859.b2     Document Type: Article

References (21)

1. Rickles FR, Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001; 102:V215-V224.
2. Rickles FR, Levine MN. Venous thromboembolism in malignancy and malignancy in venous thromboembolism. Haemostasia 1998; 28:43-49.
3. Sampson MT, Kakkar AK. Coagulation proteases and human cancer. Biochem Soc Trans 2002; 30:201-207.
4. Fernandez PM, Rickles FR. Tissue factor and angiogenesis in cancer. Curr Opin Hematol 2002; 9:401-406.
5. Gordon SG, Benson B. Analysis of serum cancer procoagulant activity and its potential as a tumor marker. Thromb Res 1989; 56:431-440.
6. Lewandowski K, Rożek M, Markiewicz T, Zawilska K. An alternative method for identifying a factor V gene Leiden mutation. Thromb Res 1997; 85:105-113.
7. Mielicki WP, Serwa J, Kurzawinski T, Wierzbicki R. Procoagulant activity of human stomach and colon cancers. Oncology 1990; 7:299-302.
8. Falanga A, Gordon SG. Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant. Biochim Biophys Acta 1985; 831:161-165.
9. Gordon SG, Cross BA. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as new tumor marker. Cancer Res 1990; 50:6229-6243.
10. Kozuszko B, Skrzydlewski Z, Sułkowska M, Snarska J, Kozłowski M, Skrzydlewska E, et al. Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer. Pol Merkuriusz Lek 2001; 11:218-220.
11. Chiang HS, Yang RS, Lin SW, Huang TF. Tissue factor activity of SW-480 human colon adeocarcinoma cells is modulated by thrombin and protein kinase C activation. Br J Cancer 1998; 78:1121-1127.
12. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, et al. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998; 4:909-914.
13. Chojnowski K, Trelinski J, Wawrzyniak E, Sobolewska M, Mielicki W. Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes. Neoplasma 2002; 49:155-158.
14. Di Micco P, Romano M, Niglio A, Nozzolillo P, Federico A, Petronel P, et al. Alteration of haemostasis in non-metastatic gastric cancer. Dig Liver Dis 2001; 33:546-550.
15. Green D, Maliekel K, Sushko E, Akhtar R, Soft GA. Activated-protein-C resistance in cancer patients. Haemostasis 1997; 27:112-118.
16. Tsuneyoshi N, Fukudome K, Horiguchi S, Ye X, Matsuzaki M, Toi M, et al. Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines. Thromb Haemost 2001; 85:356-361.
17. Inufusa H, Adachi T, Kiyokawa T, Nakatani Y, Wakano T, Nakam M, et al. Ley glycolipid-recognizing monoclonal antibody inhibits procoagulant activity and metastasis of human adenocarcinoma. Int J Oncol 2001; 19:941-946.
18. Otten H-M, Prins MH. Venous thromboembolism and occult malignancy. Thromb Res 2001; 102:187-194.
19. Sanella NA, O'Connor DJ. 'Idiopathic' deep vein thrombosis: the value of routine abdominal and pelvic computed tomographic scanninig. Ann Vasc Surg 1991; 5:218-220.
20. Schafer AI, Levine MN, Konkle BA, Kearon C. Thrombotic disorders: diagnosis and treatment. Hematol (Am Soc Hematol Educ Program) 2003;520-539.
21. Hirsh J, Weitz JI. New antithrombotic agents. Lancet 1999; 353:1431-1436.